Large nontransplanted hepatocellular carcinoma in woodchucks: Treatment with adenovirus-mediated delivery of interleukin 12/B7.1 genes

Journal of the National Cancer Institute

Volumn 93, Issue 6, 2001, Pages 472-479

  Pützer, Brigitte M ^a,d   Stiewe, Thorsten ^a   Rödicker, Florian ^a   Schildgen, Oliver ^a   Rühm, Stefan ^a   Dirsch, Olaf ^a   Fiedler, Melanie ^a   Damen, Uta ^a   Tennant, Bud ^b   Scherer, Caren ^a   Graham, Frank L ^c   Roggendorf, Michael ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b Department of Obstetrics Gynecology   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 12; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CANCER TRANSPLANTATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GENE THERAPY; GENE TRANSFER; HEPATITIS VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INJECTION; LIVER CELL CARCINOMA; LONG TERM CARE; LYMPHOCYTIC INFILTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLAQUE FORMING CELL; PRIORITY JOURNAL; STATISTICAL ANALYSIS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR REGRESSION; TUMOR REJECTION; WOODCHUCK;

EID: 0035925568     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.6.472     Document Type: Article

References (45)

1. The host-tumor immune conflict: From immunosuppression to resistance and destruction
2. Immune selection in neoplasia: Towards a microevolutionary model of cancer development
3. How tumors escape immune destruction and what we can do about it
4. Neuroblastoma regression and immunity induced by transgenic expression of interleukin-12
5. Gene transfer to liver cancer cells of B7-1 plus interleukin 12 changes immunoeffector mechanisms and suppresses helper T cell type 1 cytokine production induced by interleukin 12 alone
6. Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in murine breast cancer model
7. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors
8. Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12
9. Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression
10. Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer
11. A double recombinant adenovirus expressing the costimulatory molecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocarcinoma model
12. An adenovirus vector expressing interleukin-4 modulates tumorigenicity and induces regression in a murine breast cancer model
13. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells
14. Interleukin-12 and its role in the generation of TH1 cells
15. Inhibition of angiogenesis in vivo by interleukin 12
16. Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors
17. Tumour cell expression of B7 co-stimulatory molecules and interleukin-12 or granulocyte-macrophage colony-stimulating factor induces a local antitumour response and may generate systemic protective immunity
18. Interleukin-12 requires initial CD80-mediated T-cell activation to support immune responses toward human breast and ovarian carcinoma
19. B7.1 and cytokines. Synergy in cancer gene therapy
20. A reassessment of the role of B7-1 expression in tumor rejection
21. Tumor-induced immune dysfunction
22. Hepatitis B virus and liver cancer: The woodchuck as an experimental model of hepadnavirus-induced liver cancer
23. The woodchuck: An animal model for hepatitis B virus infection in man
24. Woodchuck hepatitis virus-induced carcinoma as a relevant natural model for therapy of human hepatoma
25. Phenotypic patterns of preneoplastic and neoplastic hepatic lesions in woodchucks infected with woodchuck hepatitis virus
26. Characterization of a human cell line transformed by DNA from human adenovirus 5
27. Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy
28. Methods for construction of adenovirus vectors
29. Construction and propagation of human adenovirus vectors
30. Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma
31. Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12
32. Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12
33. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination
34. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma
35. B cells inhibit induction of T cell-dependent tumor immunity
36. Primary chemically induced tumors induce profound immunosuppression concomitant with apoptosis and alterations in signal transduction in T cells and NK cells
37. Immunopathologic aspects of woodchuck hepatitis
38. Mammalian hepatitis B viruses and primary liver cancer
39. Animal models of hepatocellular carcinoma: Hepadnavirus-induced liver cancer in woodchucks
40. Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma
41. Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts
42. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12
43. Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection
44. Antigen presentation by MHC class I and its regulation by interferon gamma
45. Interleukin-7/ B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors